PURPOSE:
Correction of craniosynostosis has been wellestablished to be safe and to have sustainable results in infants. Timing of surgery, however, has remained variable based on surgical training and professional biases. This study sought to evaluate the impact of surgical timing on craniosynostosis management utilizing data from the National Surgical Quality Improvement Program (Pediatric NSQIP).
METHODS AND MATERIALS:
All available Pediatric NSQIP data through 2016 was acquired and cranioplasty cases were selected using current procedural terminology (CPT) codes 61550, 61552, 61556, 61557, 61558, 61559 and 21175. Cases were split by patient age into four-month age intervals: 0 to <4 months, 4 to <8 months, 8 to <12 months, and 12+ months. Perioperative variables were compared between age groups, including comorbidities, total length of stay (LOS), operative time, American Society of Anesthesiologists (ASA) physical status classification, thirty-day readmissions, thirty-day reoperations, and wound infection rate. Data was analyzed in JMP statistical software (SAS Institute, Cary, NC).
EXPERIENCE:
A total of 3,926 patients were segregated into age groups based on four-month age intervals.
RESULTS:
There were significant differences between the age groups by ASA class (p<0.0001) and wound class (p<0.0001). A greater percentage of patients younger than 4 months were ASA class I (24.37%) compared to patients who were older than 12 months (8.92%). Conversely, a greater percentage of patients older than 12 months were ASA classes III and IV (37.38%) compared to patients younger than 4 months (20.90%). The operative time varied significantly by age group (p<0.0001 by chi-square); patients younger than 4 months had a mean operative time of 96.6 minutes, and patients older than 12 months had a mean operative time of 259.7 minutes. The length of stay also varied significantly by age group (p<0.0001). The four age groups had significantly different rates of post-operative morbidity (p<0.0001), transfusion requirement (p<0.0001), and unexpected reoperations (p<0.0001) and readmissions (p=0.037) in the first thirty days by chi-square testing.
Patients younger than four months had lower risks of tracheostomy (p<0.0001), better sterility (p=0.0048), and a greater percentage of patients in ASA classes I and II (p<0.0001) compared to patients older than four months. As expected, the patients younger than four months of age also had shorter operation times (p<0.0001) and shorter lengths of stay (p=0.0008). Postoperatively, patients younger than four months had fewer unexpected reoperations (p=0.0008), readmissions (p=0.0377), and complications (p<0.0001), including fewer bleeding complications (p<0.0001).
CONCLUSION:
Patients receiving surgery at younger than four months of age tended to have lower ASA class, with shorter procedures, less post-operative morbidity, and shorter lengths of stay. Patients older than twelve months had significantly higher ASA class, more comorbidities, longer operations and lengths of stay, and higher thirtyday reoperation and readmission rates. After a multivariate analysis, age was the single most important factor for craniosynostosis complications, increased length of stay, and readmission. Parents of patients greater than 12 months of age should be counseled about the increased risk profile in this population. BACKGROUND: While cranioplastic reconstructive strategies in adults include autologous bone grafts, bone substitutes, and alloplastic materials, there remains a hesitation to reconstruct pediatric cranial defects with synthetic material when paucity of autologous bone graft exists. Pediatric cranioplasty incurs challenges of increased bone resorption, timing, cranial growth, limited donor allograft, and longer exposure to foreign materials as a nidus for infection. Effect on cranial growth after cranioplasty in children is not fully elucidated. Herein, we review the cranial growth of pediatric patients who underwent cranioplasty at our institution.
Does Autologous vs. Alloplastic Cranioplasty Affect Cranial Growth

METHODS:
After IRB approval, a retrospective single institution review was conducted from a database of pediatric patients who underwent cranioplasty from 2000 to 2017. Patients without pre-operative, short-term (< 3 months) post-operative, and long-term (>11 months) post-operative imaging were excluded. Patients were divided into alloplastic vs. autologous reconstruction cohorts. Demographics, co-morbidities, age at surgery, etiology and size of cranial defect, type of reconstruction, time of initial surgery to reconstruction, and complications were assessed. 3D surface models were created from CT data and set to the Frankfort horizontal line, which allowed for calculation of cephalometrics pre and post-operatively including cranial growth. These cohorts were then compared to an age-specific database of 3D cranial imaging in normal subjects for assessment of growth patterns.
1 Statistical analysis was performed using SPSS version 22.0.
RESULTS:
Thirty-two patients met inclusion criteria for reconstructive cranioplasty (8 mos -18 years, mean 9.6 years). Cephalic length, width, and 3D measurements were obtained to calculate the cephalic index at varying time points. Etiology of cranial defects included trauma (50%), neoplasm (12.5%), cerebral vascular accident (12.5%), epilepsy (9%), congenital cranial defect (9%), and herniation (4%). Twenty-three patients underwent autologous bone flap reconstruction, 7 underwent alloplastic reconstruction, and 2 underwent a combination of both. In long-term follow up, 3 alloplastic implants were lost to infection. Five autologous bone flaps were lost to infection and replaced with alloplastic materials. An additional 3 autologous bone flaps were revised due to nonunion or resorption. A total of 8 autologous and 3 alloplastic cranioplasties failed respectively. Cranial index at pre-operative, post-operative, and long-term follow up did not significantly differ between autologous vs. alloplastic cranioplasties at each age group (p= 0.05 -0.89) 1 . When compared to normative CI means, there was also no significant difference at each age group (p=0.08-0.99).
CONCLUSION:
Both autologous and alloplastic cranioplasty do not appear to affect cranial growth patterns in children as compared to normative data. There was a higher failure rate in autologous cranioplasty compared to alloplastic cranioplasty. There does not appear to be a significant difference in cranial growth between autologous and alloplastic cranioplasty.
